Recently, Professor Frédéric Veyrier at the Institut national de la recherche scientifique (INRS) and his team developed a new genetic tool based on a family of specific enzymes called Ssn that allows ...

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all.